<DOC>
	<DOCNO>NCT00763503</DOCNO>
	<brief_summary>This multicenter , open-label study assess systemic plasma level calcitriol , calcium homeostasis safety adult plaque-type psoriasis condition maximize use CD 2027 3Âµg/g oily spray twice daily ( 6 g daily ) , apply 20 % BSA 3 week . There total six visit : Pre-treatment period ( Day -15 , Day -8 Day -1 ) Treatment period ( Day 1/ Baseline , Day 15 Day 22 ) .</brief_summary>
	<brief_title>Pharmacokinetic ( PK ) Pharmacodynamic ( PD ) Study CD 2027 Spray Adults With Plaque-type Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<criteria>Diagnosis plaquetype psoriasis involve 10 % 20 % body surface area ( BSA ) , Global Severity Score least 3 ( moderate ) Other type psoriasis ( plaque ) Significant abnormal lab finding Secondary hyperparathyroidism Vit D deficiency Hypercalcemia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>psoriasis</keyword>
	<keyword>PK</keyword>
	<keyword>calcitriol</keyword>
</DOC>